UMIN ID: UMIN000034206
Registered date:21/09/2018
Clinical outcome of trabectedin in Japanese patients with soft tissue sarcoma; JMOG multicenter study
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Malignant soft tissue tumor |
Date of first enrollment | 2017/09/22 |
Target sample size | 200 |
Countries of recruitment | Japan |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | Progressive-free survival |
---|---|
Secondary Outcome | Survival Side effect (CTCAE) |
Key inclusion & exclusion criteria
Age minimum | Not applicable |
---|---|
Age maximum | Not applicable |
Gender | Male and Female |
Include criteria | |
Exclude criteria | Patients who are not treated in the registered institutions of Japanese Musculoskeletal Oncology Group will be excluded from this study. |
Related Information
Primary Sponsor | Japanese Musculoskeletal Oncology Group |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Japanese Musculoskeletal Oncology Group |
Secondary ID(s) |
Contact
public contact | |
Name | Hiroshi Kobayashi |
Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan 113-8655 |
Telephone | 03-3815-5411 |
hkobayashi-tky@umin.ac.jp | |
Affiliation | The University of Tokyo Hospital Orthopaedic department |
scientific contact | |
Name | Sakae Tanaka |
Address | 7-3-1, Hongo, Bunkyo-ku, Tokyo Japan |
Telephone | 03-3815-5411 |
tanakas-ort@h.u-tokyo.ac.jp | |
Affiliation | The University of Tokyo Hospital Orthopaedic department |